Skip to content

Mindfulness Based Cognitive Therapy for Fear of Recurrence in Ovarian Cancer Survivors. (FROCS)

Mindfulness Based Cognitive Therapy for Fear of Recurrence in Ovarian Cancer Survivors. (FROCS)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615000213549
Acronym
FROCS
Enrollment
20
Registered
2015-03-05
Start date
2015-03-09
Completion date
2019-05-06
Last updated
2021-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study will determine the effect of mindfulness based cognitive therapy on the fear of recurrence in ovarian cancer survivors. Who is it for? You may be eligible to join this study if you are aged 18 years or above and have been diagnosed with ovarian cancer, have completed all hospital based adjuvant treatment and are now disease free. Study details All participants will receive the same intervention and will involve intensive training and practice in mindfulness based cognitive therapy. Treatment is designed as an 8 week course of 2-2.5 hour small group sessions once weekly with approximately 8-15 individuals in each group. Sessions are run at locations in Shenton Park, Duncraig and East Fremantle by the Cancer Council WA, or by SolarisCare Foundation, at Sir Charles Gardner Hospital in Nedlands. Courses take place during the day and are free of charge. The groups will be run by experienced clinicians in psychotherapy, counselling and meditation and will have a clinician manual and a participant workbook outlining the themes and exercises for each week. Group members will be expected to practice skills between sessions. Participants will be asked to answer questionnaires before, during and after the group sessions to collect information on how participants are feeling.

Interventions

Mindfulness Based Cognitive Therapy. Mindfulness based cognitive therapy is a group program that is generally used to delay or prevent recurrence of major depression, but may also reduce depressive symptoms. The treatment combines the clinical application of mindfulness meditation with elements of cognitive-behavioral therapy, and was first developed in 2000. Mindfulness is purposeful, nonjudgmental attention to the present moment, which is developed through meditation and other practices. CBT i

Mindfulness Based Cognitive Therapy. Mindfulness based cognitive therapy is a group program that is generally used to delay or prevent recurrence of major depression, but may also reduce depressive symptoms. The treatment combines the clinical application of mindfulness meditation with elements of cognitive-behavioral therapy, and was first developed in 2000. Mindfulness is purposeful, nonjudgmental attention to the present moment, which is developed through meditation and other practices. CBT is based upon the theory that maladaptive thoughts and behaviors lead to psychopathology; the clinician and patient identify these dysfunctional cognitions and the patient tries to change the resulting problematic behaviors. There are similarities between mindfulness based cognitive therapy and CBT. Both treatments teach patients to identify triggers and symptoms of relapse such as anxiety and depression, and to develop a behavior plan for avoiding relapse. Other similarities include directing patients to observe their thoughts and to rate activities for the pleasure and sense of mastery they provide. What distinguishes mindfulness based cognitive therapy is its emphasis upon accepting dysfunctional thoughts. In contrast, CBT emphasizes changing dysfunctional thoughts by gathering evidence to dispute their validity. The MBCT course comprises 8 weekly sessions with each session being approximately 2 hours. The duration of the course is 8 weeks and the sessions take place in groups of 8-15 individuals. The groups will be run by experienced clinicians in psychotherapy, counselling and meditation and will have a clinician manual and a participant workbook outlining the themes and exercises for each week. Adherence is monitored by discussion of issues which may arise during practice of the techniques in between sessions.

Sponsors

Dr Paul Cohen
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

- Have a confirmed diagnosis of primary or recurrent epithelial ovarian carcinoma (any histopathological subtype and any stage of disease at diagnosis) - Are being treated with curative intent - Have completed all hospital-based adjuvant treatments - Are disease-free - Are fluent in English - Are over 18 years of age

Exclusion criteria

- Germ cell or stromal tumours - Currently have severe major depression with suicidal ideation - Are currently receiving psychological treatment - Currently have active psychotic illness or psychiatric/cognitive condition.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 20, 2026